Edward Reich

Q: What Schools Are Affiliated With Edward Reich

Edward Reich is affiliated with the following schools: University of California, Berkeley, Stanford University, Rockefeller University, Brandeis University, Harvard University

Edward Reich's AcademicInfluence.com Rankings

Edward Reich

Biology

#5679

World Rank

#8216

Historical Rank

Biochemistry

#692

World Rank

#792

Historical Rank

biology Degrees

Download Badge

Biology

Edward Reich's Degrees

Bachelors Biochemistry University of California, Berkeley
PhD Biochemistry Stanford University

Why Is Edward Reich Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Edward Reich's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A study of proteases and protease-inhibitor complexes in biological fluids (1978) (792)
AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES (1973) (780)
SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES (1974) (699)
Antibodies to plasminogen activator inhibit human tumor metastasis (1983) (635)
Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm (1976) (559)
Effect of Actinomycin D on Cellular Nucleic Acid Synthesis and Virus Production (1961) (522)
Base Specificity in the Interaction of Polynucleotides with Antibiotic Drugs (1965) (474)
Fluorescence studies of nucleotides and polynucleotides. I. Formycin, 2-aminopurine riboside, 2,6-diaminopurine riboside, and their derivatives. (1969) (473)
Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation (1975) (427)
Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue (1979) (419)
Proteases and biological control (1975) (402)
Actinomycin and nucleic acid function. (1964) (395)
Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides (1976) (394)
ACTION OF ACTINOMYCIN DON ANIMAL CELLS AND VIRUSE (1962) (372)
Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator. (1974) (334)
Basis of actinomycin action. I. DNA binding and inhibition of RNA-polymerase synthetic reactions by actinomycin. (1962) (305)
FIBRINOLYSIS ASSOCIATED WITH ONCOGENIC TRANSFORMATION (1973) (304)
A proenzyme form of human urokinase. (1982) (297)
AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES (1973) (276)
Isolation and characterization of urokinase from human plasma. (1982) (252)
Structure and Activity of Acetylcholine (1970) (239)
Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate (1977) (234)
Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors (1977) (231)
Actinomycin: Correlation of Structure and Function of Its Complexes with Purines and DNA (1964) (212)
ACTIVATION OF PLASMINOGEN: A GENERAL MECHANISM FOR PRODUCING LOCALIZED EXTRACELLULAR PROTEOLYSIS (1978) (211)
PROPERTIES OF PLASMINOGEN ACTIVATORS FORMED BY NEOPLASTIC HUMAN CELL CULTURES (1974) (201)
The human tissue plasminogen activator gene. (1986) (199)
Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. (1985) (195)
The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus. (1973) (178)
X-Ray Diffraction and Molecular Model Building Studies of The Interaction of Actinomycin with Nucleic Acids (1963) (174)
BIOCHEMISTRY OF ACTINOMYCINS. (1963) (166)
Experimental model for quantitative study of metastasis. (1980) (157)
Merocyanine 540 as a fluorescent probe of membranes: Selective staining of leukemic and immature hemopoietic cells (1978) (150)
Acetylcholine receptor. Responses to drug binding. (1977) (148)
Action of actinomycin D on animal cells and viruses. (1962) (137)
Structure-Activity Correlations of Actinomycins and their Derivatives (1962) (134)
A specific labeling procedure for proteins on the outer surface of membranes. (1972) (132)
Macrophage plasminogen activator: induction by products of activated lymphoid cells (1977) (129)
Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. (1974) (127)
Fibrinolysis associated with oncogenic transformation. Morphological correlates. (1974) (126)
Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. (1971) (125)
Plasminogen activator in chick fibroblasts: Induction of synthesis by retinoic acid; synergism with viral transformation and phorbol ester (1978) (123)
Differentiation of early mouse embryonic and teratocarcinoma cells in vitro: plasminogen activator production. (1976) (120)
Merocyanine 540 as a fluorescent probe of membranes: Staining of electrically excitable cells (1978) (114)
Gene expression and cAMP. (1985) (111)
Effect of mitomycin C on mammalian cells in culture. (1962) (110)
Changes in malignant phenotype of a human carcinoma conditioned by growth environment (1983) (105)
Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells (1983) (102)
BIOLOGICAL AND BIOCHEMICAL PROPERTIES OF THE ANALOGUE ANTIBIOTIC TUBERCIDIN. (1964) (97)
Plasminogen activator in the bursa of Fabricius: Correlations with morphogenetic remodeling and cell migrations (1981) (95)
Fibrin overlay methods for the detection of single transformed cells and colonies of transformed cells (1975) (92)
Plasminogen activator: Induction of synthesis by DNA damage (1980) (90)
Serine enzymes released by cultured neoplastic cells (1978) (90)
Macrophage plasminogen activator: induction by asbestos is blocked by anti-inflammatory steroids (1976) (89)
An inhibitor of plasminogen activation from human placenta. Purification and characterization. (1987) (88)
Arachidonoyl-CoA synthetase. Separation from nonspecific acyl-CoA synthetase and distribution in various cells and tissues. (1985) (87)
cDNA and gene nucleotide sequence of porcine plasminogen activator. (1984) (83)
Specific protease deficiency in polymorphonuclear leukocytes of Chediak- Higashi syndrome and beige mice (1978) (81)
RNA METABOLISM OF B. SUBTILIS. EFFECTS OF ACTINOMYCIN. (1963) (81)
Plasminogen activator in chick embryo muscle cells: Induction of enzyme by RSV, PMA and retinoic acid (1978) (79)
Effect of mitomycin C on the growth of some animal viruses. (1961) (78)
Bacteriocidal action of mitomycin C. (1960) (77)
Induction and desensitization of plasminogen activator gene expression by tumor promoters. (1985) (75)
Chromosomal locations of human tissue plasminogen activator and urokinase genes. (1985) (72)
Biochemical studies of the nucleoside analogue, formycin. (1969) (72)
Plasminogen activator of islets of Langerhans: modulation by glucose and correlation with insulin production. (1980) (71)
The interaction of actinomycin with DNA: requirement for the 2-amino group of purines. (1967) (70)
Calcitonin stimulates plasminogen activator in porcine renal tubular cells: LLC-PK1 (1981) (69)
ACTINOMYCIN INHIBITION OF RNA SYNTHESIS DIRECTED BY DNA. (1964) (68)
RNA and protein synthesis in human peripheral blood polymorphonuclear leukocytes (1979) (64)
Isolation and characterization of Clostridium botulinum type B toxin. (1969) (63)
SEPARATION OF THE BIOSYNTHESIS OF THE ANTIBIOTIC POLYPEPTIDE TYROCIDINE FROM PROTEIN BIOSYNTHESIS. (1963) (61)
Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction. (1979) (58)
Plasminogen activators of the pituitary gland: enzyme characterization and hormonal modulation (1983) (58)
Neurotoxin from venom of the cobra, Naja naja siamensis. Purification and radioactive labeling. (1972) (56)
Muscle differentiation in cell culture. Effects of nucleoside inhibitors and Rous sarcoma virus. (1972) (55)
Modulation of plasminogen activator synthesis in chick embryo fibroblasts by cyclic nucleotides and phorobol myristate acetate. (1979) (54)
Modulation of plasminogen activator in rodent mammary tumors by hormones and other effectors. (1983) (54)
Cytotoxic T cells both produce and respond to interleukin 2 (1984) (54)
Loss of malignancy during serial passage of human carcinoma in culture and discordance between malignancy and transformation parameters. (1980) (52)
The murine urokinase-type plasminogen activator gene. (1987) (52)
Lipid studies of Rous sarcoma virus and host cell membranes. (1972) (51)
Conformational properties of polyformycin: a polyribonucleotide with individual residues in the syn conformation. (1968) (51)
Fluorescence studies of nucleotides and polynucleotides. I. (1969) (48)
Procedures in Nucleic Acid Research. G. L. Cantoni and David R. Davies, Eds. Harper and Row, New York, 1966. 683 pp., illus. $25 (1967) (47)
An improved assay for interleukin 2 (lymphocyte growth factor) produced by mitogen-activated lymphocytes. (1980) (47)
Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors. (1980) (46)
Crystal structure of the proenzyme domain of plasminogen. (1999) (46)
Inhibition of Ribonucleic Acid-Polymerase Reactions by Actinomycin and Proflavine (1963) (45)
DEGRADATION OF RIBONUCLEIC ACID IN MOUSE FIBROBLASTS TREATED WITH ACTINOMYCIN (1965) (44)
Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity (1981) (43)
Isolation and characterization of a Mr = 38,000 protein from differentiating smooth muscle cells. (1985) (43)
Transglutaminase-catalyzed insertion of a fluorescent probe into the protease-sensitive region of rhodopsin. (1978) (42)
Properties of the nicotinic acetylcholine receptor macromolecule of Electrophorus electricus (1972) (40)
Metabolism of acetylcholine receptor in chick embryo muscle cells: Effects of RSV and PMA (1978) (40)
Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma. (1985) (35)
Complex-formation and inhibition of urokinase by blood plasma proteins. (1983) (33)
Selective lysis of cells transformed by Rous Sarcoma virus. (1971) (31)
Pyrrolopyrimidine nucleotides and protein synthesis. (1968) (31)
Antibodies to interleukin 2. Effects on immune responses in vitro and in vivo (1984) (31)
Modulation and mapping of a human plasminogen activator by cell fusion (1978) (30)
Basis of actinomycin action. II. Effect of actinomycin on the nucleoside triphosphate-inorganic pyrophosphate exchange. (1963) (29)
Some stereochemical requirements of Escherichia coli ribonucleic acid polymerase. Interaction with conformationally restricted ribonucleoside 5'-triphosphates: 8-bromoguanosine, 8-ketoguanosine, and 6-methylcytidine triphosphates. (1971) (28)
Bacteriocidal action of mitomycin C. (1961) (27)
Isolation of a mutant LLC-PK1 cell line defective in hormonal responsiveness. A pleiotropic lesion in receptor function. (1986) (26)
Effects of 2:4-dinitrophenol and other agents on the nucleoside triphosphatase activities of L-myosin. (1956) (25)
Studies of Rous sarcoma virus. Effects of nucleoside analogues on virus synthesis. (1973) (25)
Stereochemical analysis of the specificity of pancreatic RNAse with polyformycin as substrate: differentiation of the transphosphorylation and hydrolysis reactions. (1969) (25)
Induction of plasminogen activator synthesis by antibodies (1981) (24)
Analysis of transcription in vitro using purine nucleotide analogs. (1971) (23)
Fluorescence studies of nucleotides and polynucleotides. II. 7-Deazanebularin: coding ambiguity in transcription with base pairs containing fewer than two hydrogen bonds. (1972) (23)
Oxidative phosphorylation and some related phenomena in pigment granules of mouse melanomas. (1961) (23)
Ammonium ions as the source of nitrogen for tryptophan biosynthesis in whole cells of Escherichia coli. (1967) (20)
REQUIREMENT OF PLASMINOGEN FOR CORRELATED CHANGES IN CELLULAR MORPHOLOGY~ COLONY FORMATION IN AGAR~ AND CELL MIGRATION* (1973) (19)
On the interaction between cobra alpha-neurotoxin and the acetylcholine receptor. (1976) (19)
Diamphotoxin. The arrow poison of the !Kung Bushmen. (1983) (19)
Synthesis of ribonucleic acid containing 6-thioguanylic acid residues. (1973) (18)
Plasminogen in the chick embryo. Transport and biosynthesis. (1981) (17)
Isolation of nuclei of Neurospora crassa. (1961) (16)
Fluorescence studies of nucleotides and polynucleotides. 3. Diphosphopyridine nucleotide analogues which contain fluorescent purines. (1972) (15)
Acetylcholine receptor: effects of proteolysis on receptor metabolism (1982) (15)
Purification and characterization of a plasminogen activator secreted by a pig kidney cell line. (1984) (14)
Binding of Actinomycin As a Model for the Complex-Forming Capacity of DNA (1964) (14)
7-Deazanebularin. Metabolism in cultures of mouse fibroblasts and incorporation into cellular and viral nucleic acids. (1972) (14)
Structure and function of microplasminogen: I. Methionine shuffling, chemical proteolysis, and proenzyme activation (1995) (14)
Conversion of cholesterol to corticosteroids in adrenal homogenates. (1955) (13)
Effects of nucleoside analogs on transcription of simian virus 40. (1972) (13)
Structure and function of microplasminogen: II. Determinants of activation by urokinase and by the bacterial activator streptokinase (1995) (12)
Site-specific mutagenesis of the histidine precursor of diphthamide in the human elongation factor-2 gene confers resistance to diphtheria toxin. (2006) (11)
A proenzyme from chicken plasma similar to human plasma prekallikrein. (1983) (9)
Neutral proteinases of leucocytes and the inflammatory process. (1979) (8)
Specificity of Rous sarcoma virus synthesis (1972) (8)
Eicosadiynoic acid: a non-toxic inhibitor of multiple enzymatic steps in the production of icosanoids from arachidonic acid. (1987) (7)
7-Deazanebularin. Coding properties of triplets and polynucleotides. (1972) (6)
Secretion of Enzymes by Neoplastic Cells and Macrophages (1974) (6)
Structure of Acetylcholine (1971) (5)
Effect of mitomycin on mammalian cells in culture. Abstr. (1961) (5)
Biochemical and biological properties of 5-bromotubercidin: differential effects on cellular DNA-directed and viral RNA-directed RNA synthesis. (2008) (4)
AGONIST—ANTAGONIST DISCRIMINATION BY SOLUBILIZED ACETYLCHOLINE RECEPTOR (1976) (4)
Tubercidin and Related Pyrrolopyrimidine Antibiotics (1967) (3)
CONSTRUCTION AND EXPRESSION OF HYBRID PLASMINOGEN ACTIVATOR GENES (1987) (3)
Experimental Model for Quantitative Study of Metastasis1 (2006) (2)
Coagulation and Fibrinolysis: Characterization of the Human Prothrombin and Human Tissue-Plasminogen Activator Genes (1985) (2)
DIFFERENTIAL EFFECTS OF RIBONUCLEOSIDE ANAIOGUES ON VIRUS-DIRECTED RNA SYNTHESIS (1999) (1)
Selective Irreversible Inactivation of Replicating Mengovirus by Nucleoside Analogues: a New Form of Viral Interference (1999) (1)
Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication. (2002) (1)
Mapping Tissue Plasminogen Activator and Urokinase Genes to Human Chromosomes (1985) (1)
The role of plasminogen activator in cell migration and morphogenesis in the bursa of Fabricius. (1982) (1)
EPA's New Environmental Appeals Board (2016) (1)
Effect of vitamin A on plasminogen activator synthesis by chick embryo fibroblasts. (1979) (0)
ACTINOMYCINRELATIVE ACTIVITYArsmo ACIDRESIDUEIN POSITION S OFcHAINABC (2006) (0)
Purification and properties of a nicotinic receptor from Electrophorus electricus. (1973) (0)
1114 – PHARMACOLOGICAL PROPERTIES OF THE SOLUBILIZED ACETYLCHOLINE RECEPTOR FROM ELECTROPHORUS ELECTRICUS (1977) (0)
An Update of Some U.S. Home Furnishing Trends (1988) (0)
Biochemical Aspects of Neurotransmitter Receptors (2011) (0)
SECRETION OF PLASMINOGEN A CTIVATOR BY STIMULATED MACROPHAGES (1974) (0)
Structure and function of microplasminogen: reconstitution of microplasminogen and microplasmin from isolated fragments. (1997) (0)
Acetylcholine Receptor : Effectsof Proteolysison Receptor Metabolism (1982) (0)
Modulationof PlasminogenActivatorSynthesisin Chick Embryo Fibroblastsby Cyclic Nucleotidesand PhorobolMyristate Acetate (2006) (0)
Plasminogen Activators of the Enzyme Characterization and Pituitary Gland: Hormonal Modulation (1983) (0)
Biochemical Methods: Procedures in Nucleic Acid Research . G. L. Cantoni and David R. Davies, Eds. Harper and Row, New York, 1966. 683 pp., illus. $25. (1967) (0)
"Clean Air Act Civil Stationary Source Penalty Policy", dated October 25, 19&1, issued by (1995) (0)
Guidance on landowner liability under Section 107(a)(1) of CERCLA, de minimis settlements under Section 122(g)(1)(b) of CERCLA, and settlements with prospective purchasers of contaminated property (1989) (0)
Plasminogen activator: analysis of enzyme induction by ultraviolet irradiation mapping (1981) (0)
II. MAMMALL~N FIBROBLAST CULTURES TRANSFORMED BY DNA AXD RNA TI;~IOR VIRUSES (1973) (0)
CATALYTIC DOMAIN OF PLASMINOGEN (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Edward Reich?

Edward Reich is affiliated with the following schools: